The field of oncology is being transformed by a deeper understanding of the molecular drivers of cancer, leading to the development of highly targeted therapies. Insights published by WiseGuy Reports highlight the key isocitrate dehydrogenase inhibitors market trends that are reshaping the sector, with the market projected to grow from 1.36 billion USD in 2024 to 3.2 billion USD by...